
News|Articles|May 1, 2024
Espansione Group: Illuminating the Future of AMD Treatment: The Breakthrough of LightWave I Trial with PBM Technology
Advertisement
Advertorial: Espansione Group: Illuminating the Future of AMD Treatment:
The Breakthrough of LightWave I Trial with PBM Technology
Espansione Group, a global leader in photobiomodulation (PBM), has marked its presence with significant advancements in ophthalmology and beyond. After a decade where it has made significant strides, especially in the anterior segment of the eye, the company is now pioneering its application for the posterior pole, venturing into new territory with treatments for Age-Related Macular Degeneration (AMD), specifically in its early stages (i.e.,dry AMD).
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FLORetina-ICOOR 2026: AI moves from the image to the trial, the clinic, and the operating room
2
Water-soluble CBD eye drops lower IOP and dampen corneal sensitivity in glaucoma mouse model
3
BL1332 misses primary end point in phase 2 post-PRK ocular pain study
4
Q&A: GLP-1 RAs and NAION, the case for a baseline exam
5











